A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 16567711.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors assessed the efficacy of bromocriptine in nonfluent aphasia after stroke in a 16-week, randomized, double-blind, placebo-controlled clinical trial conducted from June 2002 to April 2004. In all 38 patients after 4 months of treatment, improvement in both the bromocriptine and placebo treatment groups was observed (p < 0.001). The analysis of repeated-measures analysis of variance revealed bromocriptine did not improve nonfluent aphasia.
Medical subject headings
- Aphasia, Broca
- Bromocriptine
- Stroke